Concepedia

Dose-related efficacy and bleeding complications of double-chain tissue plasminogen activator in acute myocardial infarction

Zoltan G. Turi, Sheldon Goldberg, Judith K. LittleJohn, Condon R. Vanderark, Neal Shadoff, Ronald P. Karlsberg, John Williams, Samuel Butman, Michael L. Stadius, Maurice Buchbinder,

The American Journal of Cardiology · 1993 · 16 citations · 19 references

DOI

Concepts

References

19

TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION

Robert G. Wilcox, Carl Olsson, Allan M. Skene et al. · The Lancet · 1988 · 1.2K citations

, , +10

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

The Lancet · 1992 · 922 citations

, , +16

ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

D Hunt, George Varigos, F Dienstl et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1992 · 898 citations

, , +12

HOME OR AWAY?

Barr Jb, Ralston Gj · PubMed · 1964 · 507 citations

Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction

Edwin G. Bovill, Michael L. Terrin, David C. Stump et al. · Annals of Internal Medicine · 1991 · 485 citations

, , +17